1973
DOI: 10.1007/bf01468567
|View full text |Cite
|
Sign up to set email alerts
|

Endogenous inhibitors of fibrinolytic activity in liver cirrhosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

1985
1985
2008
2008

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 28 publications
0
3
0
Order By: Relevance
“…18 Changes in the serum concentration of non-specific protease inhibitor have been described previously, but the results were contradictory. Normal concentrations of alpha 1-antitrypsin in cirrhotic patients was reported by Sharp et al, 19 and Aschauer et al 20 Theodoropoulos et a12' and Bogdal et a122 described increased concentration of serum alpha 1-antitrypsin in chronic hepatic disorders. Alpha 1-antitrypsin does not inhibit collagenase.…”
Section: Discussionmentioning
confidence: 79%
“…18 Changes in the serum concentration of non-specific protease inhibitor have been described previously, but the results were contradictory. Normal concentrations of alpha 1-antitrypsin in cirrhotic patients was reported by Sharp et al, 19 and Aschauer et al 20 Theodoropoulos et a12' and Bogdal et a122 described increased concentration of serum alpha 1-antitrypsin in chronic hepatic disorders. Alpha 1-antitrypsin does not inhibit collagenase.…”
Section: Discussionmentioning
confidence: 79%
“…Antithrombin III is the most important natural inhibitor of blood coagulation. Its activity is frequently decreased in patients with acute and chronic liver disease [1,5,8,11,28,44,51,61,65,70]. In acute hepatic failure it drops to very low values [23].…”
Section: Coagulation Inhibitorsmentioning
confidence: 99%
“…Alpha 2 -macroglobulin, an inhibitor of thrombin and of plasmin, is increased in liver cirrhosis [5,50,79].…”
Section: Coagulation Inhibitorsmentioning
confidence: 99%